ArticleThe Journal of dermatology2026

Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.

Ryo Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.